![David Hughes Scales](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Hughes Scales
Director/Miembro de la Junta en CN Bio Innovations Ltd. .
Cargos activos de David Hughes Scales
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CN Bio Innovations Ltd.
![]() CN Bio Innovations Ltd. BiotechnologyHealth Technology CN Bio Innovations Ltd. develops and supplies bioengineered solutions. Its products include liver chip system, tissue flex system, contract research services, drug safety profiling, drug metabolism, bespoke tissue models & applications development and technical support. The company was founded by Dr. Tim Hart on February 28, 2008 and is headquartered in Begbroke, the United Kingdom. | Director/Miembro de la Junta | - | - |
Historial de carrera de David Hughes Scales
Antiguos cargos conocidos de David Hughes Scales.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
GlycoForm Ltd.
![]() GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Presidente | 01/01/2008 | 31/08/2011 |
Cerogenix Ltd.
![]() Cerogenix Ltd. Miscellaneous Commercial ServicesCommercial Services Cerogenix Ltd. provides pharmaceutical research and development services. The company focuses on developing therapeutics for the treatment of neurological diseases such as Alzheimer's, Parkinson's, and spinal cord injuries. Cerogenix was founded in September, 2005 by Adrian Pini and is located in London, UK | Presidente | - | - |
Enhance Biotech, Inc.
![]() Enhance Biotech, Inc. BiotechnologyHealth Technology Enhance Biotech, Inc. engages in the acquisition, development and commercialization of drugs for lifestyle disorders. The company was founded on June 7, 1999 and is headquartered in New York, NY. | Director/Miembro de la Junta | - | - |
BIBRA International Ltd. | Director/Miembro de la Junta | - | - |
Charterhouse Therapeutics Ltd. | Director Técnico/Científico/I+D | - | - |
Glaxo Holdings Plc | Director Técnico/Científico/I+D | - | - |
Kyowa Kirin International Plc
![]() Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Director Técnico/Científico/I+D | - | - |
Strakan Group Ltd. | Director Técnico/Científico/I+D | - | - |
░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
Formación de David Hughes Scales.
University of London | Doctorate Degree |
University of Cardiff | Undergraduate Degree |
Estadísticas
Internacional
Reino Unido | 12 |
Estados Unidos | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 5 |
Director/Board Member | 3 |
President | 2 |
Sectorial
Health Technology | 6 |
Finance | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 10 |
---|---|
Sarossa Capital Ltd.
![]() Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Finance |
Strakan Group Ltd. | Health Technology |
Kyowa Kirin International Plc
![]() Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
Glaxo Holdings Plc | Finance |
GlycoForm Ltd.
![]() GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Health Technology |
Charterhouse Therapeutics Ltd. | |
BIBRA International Ltd. | |
Enhance Biotech, Inc.
![]() Enhance Biotech, Inc. BiotechnologyHealth Technology Enhance Biotech, Inc. engages in the acquisition, development and commercialization of drugs for lifestyle disorders. The company was founded on June 7, 1999 and is headquartered in New York, NY. | Health Technology |
Cerogenix Ltd.
![]() Cerogenix Ltd. Miscellaneous Commercial ServicesCommercial Services Cerogenix Ltd. provides pharmaceutical research and development services. The company focuses on developing therapeutics for the treatment of neurological diseases such as Alzheimer's, Parkinson's, and spinal cord injuries. Cerogenix was founded in September, 2005 by Adrian Pini and is located in London, UK | Commercial Services |
CN Bio Innovations Ltd.
![]() CN Bio Innovations Ltd. BiotechnologyHealth Technology CN Bio Innovations Ltd. develops and supplies bioengineered solutions. Its products include liver chip system, tissue flex system, contract research services, drug safety profiling, drug metabolism, bespoke tissue models & applications development and technical support. The company was founded by Dr. Tim Hart on February 28, 2008 and is headquartered in Begbroke, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- David Hughes Scales
- Experiencia